Plain-English translation of NCT02417740 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Cystic Fibrosis research guide →This is a natural history study—meaning researchers are watching and learning how a condition develops over time rather than testing a new treatment. You would be part of a group of up to 400 people who either have noncirrhotic portal hypertension (high pressure in the liver's blood vessels without scarring) or are at risk for developing it due to conditions like cystic fibrosis or other genetic disorders. The study aims to understand what causes this condition, how it gets worse, and to identify early warning signs that could help doctors better monitor and care for patients.
Many people develop dangerous high blood pressure in their liver blood vessels without having cirrhosis (liver scarring), but doctors don't fully understand why this happens or how to predict who will have serious complications. This study exists to fill that knowledge gap so doctors can better track the condition, prevent dangerous complications, and make better decisions about liver transplants.
You likely qualify if…
You likely don't qualify if…
You would attend visits where researchers collect blood samples, possibly perform a liver biopsy (taking a tiny tissue sample), measure the pressure in your liver blood vessels, and measure genetic material and microbes. You may also have imaging tests like ultrasound. The study will follow you over time to see how your condition changes, allowing doctors to develop better ways to monitor and care for people with this condition.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States